Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
News headlines Recursion Pharmaceuticals reported its Q2 2026 earnings with a narrowed net loss and progress on several clinical programs. The company is advancing in its AI-driven drug discovery ...
Infinity (Infinity Artificial Intelligence Institute), an early-stage AI infrastructure research company building the software layer that makes any AI chip inference-ready, today announced a new case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results